These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 36934698)
1. Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine. Siao WH; Chang FY; Chen YC Schizophr Res; 2023 May; 255():14-16. PubMed ID: 36934698 [No Abstract] [Full Text] [Related]
2. Memantine as a neuroprotective agent in early phases of psychosis. Fusar-Poli P; Pellegrini F; Cortesi M Med Hypotheses; 2007; 68(2):459-60. PubMed ID: 17005328 [No Abstract] [Full Text] [Related]
3. Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine. Tao J; Rosenfeld D; Hsu J; Bhatia A Cutis; 2022 Mar; 109(3):148-149. PubMed ID: 35659140 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 updates: Moderna COVID-19 vaccine (Spikevax) gains full licensure. Med Lett Drugs Ther; 2022 Feb; 64(1644):32. PubMed ID: 35175715 [No Abstract] [Full Text] [Related]
5. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021. Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ; MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654 [TBL] [Abstract][Full Text] [Related]
12. Moderna COVID-19 Vaccine Safe and Effective for Children 6 Months to 5 Years. Slomski A JAMA; 2022 Dec; 328(24):2388. PubMed ID: 36573976 [No Abstract] [Full Text] [Related]
13. Minimal change glomerulonephritis following the second dose of the Moderna COVID-19 vaccine. Park HJ; An WS; Rha SH; Kim SE; Lee SM QJM; 2022 Jul; 115(7):490-491. PubMed ID: 35380707 [No Abstract] [Full Text] [Related]
14. Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccination. Ogawa T; Aitake U; Nomura T J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e399-e400. PubMed ID: 35066922 [No Abstract] [Full Text] [Related]
15. Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2. Davila-Fernandez G; Sanchez-Moreno GV; Madrigal-Burgaleta R J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2166-2168.e1. PubMed ID: 35513307 [No Abstract] [Full Text] [Related]
16. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series. Johnston MS; Galan A; Watsky KL; Little AJ JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670 [TBL] [Abstract][Full Text] [Related]
17. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. Wilcock GK; Ballard CG; Cooper JA; Loft H J Clin Psychiatry; 2008 Mar; 69(3):341-8. PubMed ID: 18294023 [TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity to the Moderna COVID-19 Vaccine Caused by Tromethamine: PEG Is Not Always the Culprit Excipient. Azenha Rama T; Moço Coutinho R; Mota D; Moreira A; Cernadas J J Investig Allergol Clin Immunol; 2022 Oct; 32(5):414-415. PubMed ID: 34924354 [No Abstract] [Full Text] [Related]
19. Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination. Joo CW; Kim YK; Park SP Ocul Immunol Inflamm; 2022 Jul; 30(5):1250-1254. PubMed ID: 35404752 [TBL] [Abstract][Full Text] [Related]
20. Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID-19 vaccine. Ikeda T; Yokoyama K; Kawakami T J Dermatol; 2022 Dec; 49(12):e446-e447. PubMed ID: 35906789 [No Abstract] [Full Text] [Related] [Next] [New Search]